NCT05102240View on ClinicalTrials.gov

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

1,800

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Cervix Cancer

Trial Locations (1)

410210

Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial Centre, Navi Mumbai

Sponsors

Collaborators (1)

Erasmus Medical Center

All Listed Sponsors

collaborator

Bhabha Atomic Research Centre and Indian Institute of Technology, Mumbai.

UNKNOWN

collaborator

Erasmus Medical Center

OTHER

lead

Tata Memorial Hospital

OTHER_GOV